Sangamo Therapeutics, Inc (SGMO)

CIK 1001233 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sangamo Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Sep 8, 20268-K0001104659-26-105905
Aug 28, 20268-K0001193125-26-374328
Aug 17, 2026NT 10-Q0001193125-26-354282
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003615
Aug 13, 20268-K0001193125-26-347524
Aug 12, 20268-K0001193125-26-346796
Jul 20, 20268-K0001193125-26-309012
Jul 1, 20268-K0001193125-26-292501
Jun 23, 20268-K/A0001193125-26-279630
Jun 23, 20268-K0001193125-26-278582
May 27, 202640001675687-26-000008
May 27, 202640002089213-26-000008
May 27, 202640002041855-26-000010
May 27, 202640001877368-26-000008
May 27, 202640001947007-26-000012
May 15, 2026SCHEDULE 13G0001172661-26-002166
May 14, 202610-Q0001628280-26-035067
May 14, 20268-K0001628280-26-035061
Apr 30, 202610-K/A0001628280-26-028524
Apr 29, 20268-K0001628280-26-028128
Apr 23, 202640001947007-26-000010
Apr 23, 202640002041855-26-000008
Apr 22, 20261440001950047-26-003686
Apr 6, 20261440001947007-26-000008
Apr 3, 202640001877368-26-000006